Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing



Status:Withdrawn
Conditions:Hospital, Orthopedic
Therapuetic Areas:Orthopedics / Podiatry, Other
Healthy:No
Age Range:45 - Any
Updated:1/6/2018
Start Date:January 2005
End Date:January 2005

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The Evaluation of Cascade PRFM on Rotator Cuff Healing

Hypothesis: The use of cascade platelet-rich fibrin matrix (PRFM) on medium and large sized
rotator cuff tears will improve patient results versus the control results by 50%.

The purpose of this study is to examine the effect of PRFM on rotator cuff repairs. Since
locally applied platelet-derived growth factor (PDGF) has shown early promise in enhancing
tendon and ligament healing in anterior cruciate ligament (ACL) and medial collateral
ligament (MCL) reconstruction, the investigators believe that locally applied PRFM will
enhance the quality of rotator cuff repairs.


Inclusion Criteria:

- Patients 45 years of age and older who have failed conservative treatment for rotator
cuff pathology.

- Patients in this study will have full thickness rotator cuff tears that are classified
arthroscopically as medium (1 to 3 cm) or large (3 to 5 cm) and that are treated with
arthroscopic repair.

Exclusion Criteria:

- Patients who have undergone revision procedures, mini-open, or open procedures will be
excluded.
We found this trial at
1
site
Hospital for Special Surgery
535 E 70th St
New York, New York 10021
(212) 606-1000
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
?
mi
from
New York, NY
Click here to add this to my saved trials